Krystal Biotech Inc.

NASDAQ: KRYS · Real-Time Price · USD
150.11
-0.22 (-0.15%)
At close: Aug 15, 2025, 12:40 PM

Krystal Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
290.51M 50.7M n/a n/a
Cost of Revenue
20.06M 3.09M 4.05M 2.77M
Gross Profit
270.45M 47.6M -4.05M -2.77M
Operating Income
65.69M -109.73M -145.2M -68.28M
Interest Income
29.66M 22.62M 5.22M 197K
Pretax Income
95.36M 12.9M -139.97M -69.57M
Net Income
89.16M 10.93M -139.97M -69.57M
Selling & General & Admin
113.69M 98.4M 77.73M 40.39M
Research & Development
53.57M 46.43M 42.46M 27.88M
Other Expenses
37.5M 12.5M 25M n/a
Operating Expenses
204.76M 157.33M 120.2M 68.28M
Interest Expense
n/a n/a 5.22M 1.49M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
224.82M 147.93M 120.2M 68.28M
Income Tax Expense
6.2M 1.97M n/a n/a
Shares Outstanding (Basic)
28.59M 27.15M 25.49M 22.2M
Shares Outstanding (Diluted)
29.74M 27.75M 25.49M 22.2M
EPS (Basic)
3.12 0.40 -5.49 -3.13
EPS (Diluted)
3.00 0.39 -5.49 -3.13
EBITDA
109.91M 17.9M -145.2M -65.31M
EBIT
103.19M 12.9M -139.97M -69.57M
Depreciation & Amortization
6.75M 5.01M 4.05M 2.77M